Sermonix Pharmaceuticals
Columbus
About Sermonix Pharmaceuticals
Sermonix Pharmaceuticals LLC, a specialty pharmaceutical company, focuses on the development and commercialization of late-stage women’s health products. It offers lasofoxifene, a selective estrogen receptor modulator for the treatment of vulvovaginal atrophy, as well as treatment and prevention of post-menopausal osteoporosis. The company was founded in 2014 and is headquartered in Columbus, Ohio.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $67.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2021)
- Website: sermonixpharma.com
- Phone: (614)864-4919
Industries & Categories
Biopharma, Clinical Trials, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/sermonix-pharmaceuticals-97828 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.